NCT01960725View on ClinicalTrials.gov

An Alternate Dosing Schedule for Pentavalent Rotavirus Vaccine (RotaTeq)

PHASE4CompletedINTERVENTIONAL

Enrollment

66

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

May 31, 2016

Conditions

DiarrheaGastroenteritis

Interventions

BIOLOGICAL

RV5 (Pentavalent Rotavirus Vaccine)

Trial Locations (1)

27710

Duke University Health System, Durham

Sponsors

Lead Sponsor

Dennis Clements

All Listed Sponsors

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Dennis Clements

OTHER